Teno-Em

Teno-Em

tenofovir + emtricitabine

Manufacturer:

GPO

Distributor:

GPO

Marketer:

GPO
Concise Prescribing Info
Contents
Tenofovir disoproxil fumarate 300 mg, emtricitabine 200 mg
Indications/Uses
HIV-1 infection in combination w/ other antiretroviral agents eg, NNRTIs or PIs. Pre-exposure prophylaxis for prevention of HIV-1 infection.
Dosage/Direction for Use
Adult 1 tab once daily. HIV-1 Infection 1 tab once daily. Pre-exposure prophylaxis (PrEP) 1 tab once daily.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity.
Special Precautions
Lactic acidosis & severe hepatomegaly w/ steatosis. Avoid concomitant use w/ nephrotoxic agents. Co-infection w/ hepatitis B or C. Perform initial test for the presence of chronic HBV prior to antiretroviral therapy. Immune reconstitution syndrome. Lipodystrophy. Renal impairment. Monitor bone in patients w/ history of pathologic bone fracture. Carefully monitor patients on a therapy utilizing a triple nucleoside-only regimen. Childn <18 yr. Elderly. Pregnancy & lactation.
Adverse Reactions
Abnormal dreams, depression, diarrhea, dizziness, fatigue, headache, insomnia, nausea & rash. Skin discoloration.
Drug Interactions
Atazanavir, indinavir, lopinavir/ritonavir, didanosine, lamivudine, saquinavir/ritonavir, zidovudine, entecavir. Increased serum conc of tenofovir w/ acyclovir, adefovir, dipivoxil, cidofovir, ganciclovir, valacyclovir, valganciclovir.
MIMS Class
ATC Classification
J05AR03 - tenofovir disoproxil and emtricitabine ; Belongs to the class of antivirals for treatment of HIV infections, combinations.
Presentation/Packing
Form
Teno-Em film-coated tab
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in